President Donald Trump’s plan to change the pricing model for some medications is facing fierce criticism from the pharmaceutical industry before he’s even signed an executive order he says will lower the costs of drugs. Trump plans to sign the executive order Monday. The Republican president's plan is likely to tie the price of medications covered by Medicare and administered in a doctor’s office to the lowest price paid by other countries. Trump promises his executive order, if implemented, will significantly lower drug costs. But the nation’s leading pharmaceutical lobby calls Trump's plan a “bad deal” for American patients. Drugmakers argue any threats to their profits could impact their research to develop new drugs.
